Molecular Biological Approach to Estimate the Effect of Left Ventricular Repair for Chronic Heart Failure

评估左心室修复对慢性心力衰竭效果的分子生物学方法

基本信息

  • 批准号:
    12671306
  • 负责人:
  • 金额:
    $ 2.11万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2001
  • 项目状态:
    已结题

项目摘要

Both ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM) have a large left ventricular (LV) volume and a high wall tension. As a surgical treatment, LV repair (LVR) for ICM or DCM have been popular to reduce the LV volume. However, the effects of those procedures are not well understood, and we designed animal studies.LVR for ICM : ICM was developed in rats after anterior descending artery ligation. Rats were divided into LVR group or Sham group. LVR was performed by placating the infracted scar, and Sham operation was just thoracotomy. LV function was evaluated by echocardiography and cardiac catheterization. Brain natriuretic peptide (BNP) mRNA and endothelin-1 (ET-1) mRNA were measured by Nothern blot analysis. One week after surgery, LV motion and size improved in LVR group, and Emax was higher than in Sham group. However, all of them became similar 4 weeks after surgery. BNP mRNA was lower in LVR group at week 1, but not at week 4. ET-1 was higher in LVR group at week 1, but it was similar to that in Sham group at week 4.LVR for DCM : Dahl rats started an high-salt diet at the age of 7 weeks, and developed DCM about 40 weeks later. The DCM rats were randomized into LVR group or Sham group. LVR was performed by plicating the LV area between the papillary muscle bases. LV function was estimated by echocardiography and catheterization. Right after surgery, LV size decreased and LV motion improved in LVR group. LV re-dilation developed and Emax was the same level between the groups 4 weeks after surgery.Both in ICM and DCM models, LV size and function improved early after LVR, however, LV remodeling developed in late phase and deteriorated LV function. Prevention of postoperative LV remodeling is important to improve operative results.
缺血性心肌病(ICM)和扩张型心肌病(DCM)都有较大的左心室(LV)容积和较高的室壁张力。作为一种外科治疗,ICM或DCM的LV修复术(LVR)已流行以减少LV体积。然而,这些程序的效果还没有得到很好的理解,我们设计了动物实验。ICM的LVR:ICM是在大鼠前降支动脉结扎后形成的。将大鼠分为LVR组和Sham组。LVR采用瘢痕松解的方法,Sham手术采用开胸手术。通过超声心动图和心导管检查评价左室功能。采用免疫印迹法检测脑钠肽(BNP)和内皮素-1(ET-1)mRNA的表达。术后1周LVR组左室运动和大小改善,Emax高于Sham组。但术后4周,所有患者均恢复正常。LVR组BNP mRNA在第1周降低,但在第4周没有降低。DCM的LVR:Dahl大鼠7周龄开始高盐饮食,40周左右发生DCM。将DCM大鼠随机分为LVR组和Sham组。通过在乳头肌基底之间折叠LV区域进行LVR。通过超声心动图和导管插入术评估左室功能。术后即刻,LVR组的LV尺寸减小,LV运动改善。ICM和DCM模型在LVR后早期左室大小和功能均得到改善,但后期左室重构发生,左室功能恶化。预防术后左室重构对提高手术效果有重要意义。

项目成果

期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Takeshi Nishina, Kazunobu Nishimura, Sadatoshi Yuasa, Senri Miwa, Takuya Nomoto, Yutaka Sakakibara, Nobuhiro Handa, Ichiro Hamanaka, Yoshahiko Saito, Masashi Komeda: "Initial effects of the left ventricular repair by plication may not last long in a rat i
Takeshi Nishina、Kazunobu Nishimura、Sadatoshi Yuasa、Senri Miwa、Takuy​​a Nomoto、Yutaka Sakakibara、Nobuhiro Handa、Ichiro Hamanaka、Yoshahiko Saito、Masashi Komeda:“通过折叠术修复左心室的初始效果可能不会在大鼠体内持续很长时间。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takeshi Nishina: "A Rat Model of Ischemic Cardiomyopathy for Investigating Left Ventricular Volume Reduction Surgery"Journal of Cardiac Surgery. (in press).
Takeshi Nishina:“用于研究左心室减容手术的缺血性心肌病大鼠模型”心脏外科杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takeshi Nishina, Kazunobu Nishimura, Sadatoshi Yuasa, Senri Miwa, Yutaka Sakakibara, Tadashi Ikeda, Masashi Komeda: "A Rat Model of Ischemic Cardiomyopathy for Investigating Left Ventricular Volume Reduction Surgery"J Card Surg. (in press).
Takeshi Nishina、Kazunobu Nishimura、Sadatoshi Yuasa、Senri Miwa、Yutaka Sakakibara、Tadashi Ikeda、Masashi Komeda:“用于研究左心室减容手术的缺血性心肌病大鼠模型”J Card Surg。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takeshi Nishina: "Initial effects of the left ventricular repair by plication may not last long in a rat ischemic cardiomyopathy model"Circulation. 104(suppl I). I-241-I-245 (2001)
Takeshi Nishina:“在大鼠缺血性心肌病模型中,通过折叠术修复左心室的初始效果可能不会持续很长时间”循环。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sadatoshi Yuasa: "A rat model of dilated cardiomyopathy to investigate partial left ventriculectomy"Journal of Cardiac Surgery. 16. 40-47 (2001)
Sadatoshi Yuasa:“用于研究部分左心室切除术的扩张型心肌病大鼠模型”心脏外科杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NISHINA Takeshi其他文献

NISHINA Takeshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NISHINA Takeshi', 18)}}的其他基金

Research for effects of corroboration with apex sparing left ventricular repair surgery and hepatic growth factor using delivery sheet
利用产单证实保心尖左心室修复手术与肝生长因子的效果研究
  • 批准号:
    15390410
  • 财政年份:
    2003
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

Decoding Dilated Cardiomyopathy in vitro: Linking Genetic Mutations to Phenotypic Dysfunction
体外解码扩张型心肌病:将基因突变与表型功能障碍联系起来
  • 批准号:
    495567
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Miscellaneous Programs
Evaluating sex specific differences in dilated cardiomyopathy
评估扩张型心肌病的性别特异性差异
  • 批准号:
    MR/W023830/1
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Fellowship
Enabling advances in diagnosis, patient stratification and treatment for dilated cardiomyopathy patients and families (DCM Next)
促进扩张型心肌病患者和家庭的诊断、患者分层和治疗取得进展 (DCM Next)
  • 批准号:
    10085929
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
    EU-Funded
Using miRNA to identify new therapeutic pathways for dilated cardiomyopathy
使用 miRNA 确定扩张型心肌病的新治疗途径
  • 批准号:
    10740082
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
Dysregulated mechanosignaling in dilated cardiomyopathy caused by defective Filamin C
Filamin C 缺陷引起的扩张型心肌病的机械信号失调
  • 批准号:
    10877387
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
Development of strategies to enhance titin (TTN) expression and treat dilated cardiomyopathy caused by TTN haploinsufficiency
开发增强肌联蛋白 (TTN) 表达并治疗 TTN 单倍体不足引起的扩张型心肌病的策略
  • 批准号:
    10662742
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
Elucidation of pathogenesis mechanisms and exploration of therapeutic strategies using mouse models of dilated cardiomyopathy
扩张型心肌病小鼠模型阐明发病机制并探索治疗策略
  • 批准号:
    23K18221
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Discovery and Characterization of Rare Variant Effects in Dilated Cardiomyopathy via Large-Scale Biobank Analysis
通过大规模生物库分析发现和表征扩张型心肌病的罕见变异效应
  • 批准号:
    10682290
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
  • 批准号:
    10733915
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
Elucidation of Molecular Basis for Myocardial Fibrosis in Dilated Cardiomyopathy
扩张型心肌病心肌纤维化的分子基础阐明
  • 批准号:
    23K15174
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了